Onconetix, Inc. (ONCO)
NASDAQ: ONCO · IEX Real-Time Price · USD
0.156
-0.014 (-8.00%)
Jul 22, 2024, 11:22 AM EDT - Market open
Onconetix Employees
Onconetix had 12 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$63,242
Profits / Employee
-$3,806,802
Market Cap
3.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| China Pharma Holdings | 231 |
| Regional Health Properties | 114 |
| Fresh2 Group | 75 |
| iSpecimen | 53 |
| Sintx Technologies | 43 |
| Bio-Path Holdings | 10 |
| Palisade Bio | 9 |
ONCO News
- 7 days ago - Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewsWire
- 11 days ago - Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors - GlobeNewsWire
- 7 months ago - Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders - GlobeNewsWire
- 7 months ago - Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™ - GlobeNewsWire
- 9 months ago - Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company - GlobeNewsWire
- 9 months ago - Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1) - GlobeNewsWire
- 9 months ago - Blue Water Biotech Issues Letter to Shareholders - GlobeNewsWire